BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33457222)

  • 1. Consensus statements from the EAU-ESMO collaboration for advanced and variant bladder cancer: can we move the needle to improve survival?
    Packiam VT
    Transl Androl Urol; 2020 Dec; 9(6):2488-2492. PubMed ID: 33457222
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250].
    Witjes JA; Babjuk M; Bellmunt J; Bruins HM; De Reijke TM; De Santis M; Gillessen S; James N; Maclennan S; Palou J; Powles T; Ribal MJ; Shariat SF; Van Der Kwast T; Xylinas E; Agarwal N; Arends T; Bamias A; Birtle A; Black PC; Bochner BH; Bolla M; Boormans JL; Bossi A; Briganti A; Brummelhuis I; Burger M; Castellano D; Cathomas R; Chiti A; Choudhury A; Compérat E; Crabb S; Culine S; De Bari B; De Blok W; De Visschere PJL; Decaestecker K; Dimitropoulos K; Dominguez-Escrig JL; Fanti S; Fonteyne V; Frydenberg M; Futterer JJ; Gakis G; Geavlete B; Gontero P; Grubmüller B; Hafeez S; Hansel DE; Hartmann A; Hayne D; Henry AM; Hernandez V; Herr H; Herrmann K; Hoskin P; Huguet J; Jereczek-Fossa BA; Jones R; Kamat AM; Khoo V; Kiltie AE; Krege S; Ladoire S; Lara PC; Leliveld A; Linares-Espinós E; Løgager V; Lorch A; Loriot Y; Meijer R; Mir MC; Moschini M; Mostafid H; Müller AC; Müller CR; N'Dow J; Necchi A; Neuzillet Y; Oddens JR; Oldenburg J; Osanto S; Oyen WJG; Pacheco-Figueiredo L; Pappot H; Patel MI; Pieters BR; Plass K; Remzi M; Retz M; Richenberg J; Rink M; Roghmann F; Rosenberg JE; Rouprêt M; Rouvière O; Salembier C; Salminen A; Sargos P; Sengupta S; Sherif A; Smeenk RJ; Smits A; Stenzl A; Thalmann GN; Tombal B; Turkbey B; Lauridsen SV; Valdagni R; Van Der Heijden AG; Van Poppel H; Vartolomei MD; Veskimäe E; Vilaseca A; Rivera FAV; Wiegel T; Wiklund P; Willemse PM; Williams A; Zigeuner R; Horwich A
    Eur Urol; 2020 Jul; 78(1):e48-e50. PubMed ID: 32446863
    [No Abstract]   [Full Text] [Related]  

  • 3. 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease.
    Besse B; Adjei A; Baas P; Meldgaard P; Nicolson M; Paz-Ares L; Reck M; Smit EF; Syrigos K; Stahel R; Felip E; Peters S; ;
    Ann Oncol; 2014 Aug; 25(8):1475-84. PubMed ID: 24669016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.
    Vansteenkiste J; Crinò L; Dooms C; Douillard JY; Faivre-Finn C; Lim E; Rocco G; Senan S; Van Schil P; Veronesi G; Stahel R; Peters S; Felip E;
    Ann Oncol; 2014 Aug; 25(8):1462-74. PubMed ID: 24562446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the EORTC tables and the EAU categories for risk stratification of patients with nonmuscle-invasive bladder cancer.
    Rieken M; Shariat SF; Kluth L; Crivelli JJ; Abufaraj M; Foerster B; Mari A; Ilijazi D; Karakiewicz PI; Babjuk M; Gönen M; Xylinas E
    Urol Oncol; 2018 Jan; 36(1):8.e17-8.e24. PubMed ID: 28947304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical practice guidelines for the surgical management of colon cancer: a consensus statement of the Hellenic and Cypriot Colorectal Cancer Study Group by the HeSMO.
    Xynos E; Gouvas N; Triantopoulou C; Tekkis P; Vini L; Tzardi M; Boukovinas I; Androulakis N; Athanasiadis A; Christodoulou C; Chrysou E; Dervenis C; Emmanouilidis C; Georgiou P; Katopodi O; Kountourakis P; Makatsoris T; Papakostas P; Papamichael D; Pentheroudakis G; Pilpilidis I; Sgouros J; Vassiliou V; Xynogalos S; Ziras N; Karachaliou N; Zoras O; Agalianos C; Souglakos J;
    Ann Gastroenterol; 2016; 29(1):3-17. PubMed ID: 26752945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer.
    Alfred Witjes J; Lebret T; Compérat EM; Cowan NC; De Santis M; Bruins HM; Hernández V; Espinós EL; Dunn J; Rouanne M; Neuzillet Y; Veskimäe E; van der Heijden AG; Gakis G; Ribal MJ
    Eur Urol; 2017 Mar; 71(3):462-475. PubMed ID: 27375033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.
    Stenzl A; Cowan NC; De Santis M; Kuczyk MA; Merseburger AS; Ribal MJ; Sherif A; Witjes JA;
    Eur Urol; 2011 Jun; 59(6):1009-18. PubMed ID: 21454009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developments in urologic oncology «OncoForum»: The best of 2015.
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo J
    Actas Urol Esp; 2016; 40(6):361-9. PubMed ID: 27061663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Educational needs in gastrointestinal cancer: a consensus position paper from the ESMO Gastrointestinal Cancer Faculty.
    Lordick F; Obermannova R; Vola D; Douillard JY; Mcgregor K; Van Cutsem E; Tabernero J; Ciardiello F; Cervantes A
    ESMO Open; 2019; 4(3):e000533. PubMed ID: 31354964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
    Babjuk M; Böhle A; Burger M; Capoun O; Cohen D; Compérat EM; Hernández V; Kaasinen E; Palou J; Rouprêt M; van Rhijn BWG; Shariat SF; Soukup V; Sylvester RJ; Zigeuner R
    Eur Urol; 2017 Mar; 71(3):447-461. PubMed ID: 27324428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical practice guidelines for the surgical treatment of rectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).
    Xynos E; Tekkis P; Gouvas N; Vini L; Chrysou E; Tzardi M; Vassiliou V; Boukovinas I; Agalianos C; Androulakis N; Athanasiadis A; Christodoulou C; Dervenis C; Emmanouilidis C; Georgiou P; Katopodi O; Kountourakis P; Makatsoris T; Papakostas P; Papamichael D; Pechlivanides G; Pentheroudakis G; Pilpilidis I; Sgouros J; Triantopoulou C; Xynogalos S; Karachaliou N; Ziras N; Zoras O; Souglakos J;
    Ann Gastroenterol; 2016; 29(2):103-26. PubMed ID: 27064746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current topics in radiotherapy for genitourinary cancers: Consensus statements of the Genitourinary Radiation Oncologists of Canada.
    Morgan SC; Morton GC; Berlin A; Cheung P; Chung P; Ménard C; Pickles T; Souhami L; Warde PR; Lukka HR
    Can Urol Assoc J; 2020 Nov; 14(11):E588-E593. PubMed ID: 33079647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO framework.
    de Hosson LD; van Veenendaal LM; Schuller Y; Zandee WT; de Herder WW; Tesselaar MET; Klümpen HJ; Walenkamp AME
    Ann Oncol; 2017 Dec; 28(12):3022-3027. PubMed ID: 29045525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical benefit of controversial first line systemic therapies for advanced stage ovarian cancer - ESMO-MCBS scores.
    Broekman KE; Jalving M; van Tinteren H; Sessa C; Reyners AKL
    Cancer Treat Rev; 2018 Sep; 69():233-242. PubMed ID: 30098485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines].
    Stenzl A; Cowan NC; De Santis M; Kuczyk MA; Merseburger AS; Ribal MJ; Sherif A; Witjes JA;
    Actas Urol Esp; 2012 Sep; 36(8):449-60. PubMed ID: 22386114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [News with clinical relevance from major scientific meetings 2015--Update Urooncology].
    Skrobek L; Boegemann M; Hegele A
    Aktuelle Urol; 2016 Feb; 47(1):27-35. PubMed ID: 26916044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply to: MASCC/ESMO consensus recommendations for the management of nausea and vomiting in advanced cancer.
    Noble SIR; Murtagh FEM; Bausewein C; Johnson MJ
    Support Care Cancer; 2017 Oct; 25(10):2989-2990. PubMed ID: 28584933
    [No Abstract]   [Full Text] [Related]  

  • 19. Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey.
    Hendricksen K; Aziz A; Bes P; Chun FK; Dobruch J; Kluth LA; Gontero P; Necchi A; Noon AP; van Rhijn BWG; Rink M; Roghmann F; Rouprêt M; Seiler R; Shariat SF; Qvick B; Babjuk M; Xylinas E;
    Eur Urol Focus; 2019 Jul; 5(4):681-688. PubMed ID: 29074050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICUD-EAU International Consultation on Bladder Cancer 2012: Recommendations on bladder cancer-progress in a cancer that lacks the limelight.
    Soloway MS
    Eur Urol; 2013 Jan; 63(1):1-3. PubMed ID: 22868670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.